RNA
Avidity Biosciences Inc Earnings
$31.25
Earnings Summary
Revenue | $1.57Mn |
Net Profits | $-115.77Mn |
Net Profit Margins | -7360.01% |
Avidity Biosciences Inc’s revenue fell -55.6% since last year same period to $1.57Mn in the Q1 2025. On a quarterly growth basis, Avidity Biosciences Inc has generated -47.09% fall in its revenue since last 3-months.
Avidity Biosciences Inc’s net profit fell -68.14% since last year same period to $-115.77Mn in the Q1 2025. On a quarterly growth basis, Avidity Biosciences Inc has generated -13.22% fall in its net profits since last 3-months.
Avidity Biosciences Inc’s net profit margin fell -278.72% since last year same period to -7360.01% in the Q1 2025. On a quarterly growth basis, Avidity Biosciences Inc has generated -113.98% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -1.02 |
EPS Estimate Current Year | -1.02 |
Avidity Biosciences Inc’s earning per share (EPS) estimates for the current quarter stand at -1.02 - a -7.17% fall from last quarter’s estimates.
Avidity Biosciences Inc’s earning per share (EPS) estimates for the current year stand at -1.02.
Key Ratios
Earning Per Share (EPS) | 0 |
Avidity Biosciences Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Avidity Biosciences Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-08-12 | -0.95 | 0 | 100% |
2025-11-11 | -1.02 | 0 | 100% |
2025-05-08 | -0.88 | -0.9 | -2.24% |
